
|Articles|March 1, 1996
Supplements and Featured Publications
- Calcium Channel Blockers: 1995 -- The Year in Review
- Volume 2
- Issue 4 Suppl
A Provocative Interpretation of the Case Control Analysis
Advertisement
Articles in this issue
almost 30 years ago
Calcium Channel Blockers: 1995 - An Overviewalmost 30 years ago
Safety of Calcium Channel Blockers: Results of Recent Trialsalmost 30 years ago
Calcium Channel Blockers: New Trials and Trials in Progressalmost 30 years ago
Are Calcium Channel Blockers Prohemorrhagic?almost 30 years ago
Shades of Opinion: What Is Prudent?almost 30 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
2
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis
5










































